13 results
Asthma	and	Status	Asthmaticus
#Pharm #Management #Peds #Asthma #Status #Asthmaticus #Treatment #Options #Table #PEMSource
Asthma and Status ... Asthmaticus #Pharm ... #Management #Peds ... #Asthma #Status
PocketPEM - Resus Meds
#Management #Pharm	#Peds #EM	#Resus #Medications #ResusMeds #Resuscitation #PocketCard #PocketPEM
PocketPEM - Resus Meds ... #Management #Pharm ... #Peds #EM #Resus
Pediatric asthma pathway. #EM #Peds #Management #Pharm #Asthma #PediatricAsthma #StatusAsthmaticus
Pediatric asthma ... #EM #Peds #Management ... #Pharm #Asthma
Major Clinical Trials and Evidence Summary for Transfusion Thresholds in Critical Care

TRICC - NEJM 1999 -
Care TRICC - NEJM ... - ICU FOCUS - NEJM ... UGIB TRISS - NEJM ... unnecessary and cause harm ... /vmoitra) #EBM
Asthma management- what is the evidence? 

MDI vs. Nebulization of Beta agonist 
 - Has been
Asthma management ... #asthma #management ... #ebm #pulmonary ... #peds #pediatrics
Mortality after Fluid Bolus in African Children with Severe Infection - June 30, 2011 N Engl
NEJMoa1101549 #EBM ... #Peds #Pediatrics ... Boluses #Africa #NEJM
Pembrolizumab Response Rate by Tumor Type #EBM #Honc #Pharm #Pembrolizumab #Response #TumorType #Colorectal #Endometrial #Biliary #NEJM
by Tumor Type #EBM ... #Honc #Pharm #Pembrolizumab ... Endometrial #Biliary #NEJM
Effect of Tolvaptan on the Estimated Glomerular Filtration Rate (GFR). #EBM #Nephro #Pharm #Tolvaptam #PCKD #PolyCysticKidneyDisease
#EBM #Nephro #Pharm ... PolyCysticKidneyDisease #NEJM
Tezepelumab in Adults with Uncontrolled Asthma - Annualized Rate of Asthma Exacerbations at Week 52, According
with Uncontrolled Asthma ... Annualized Rate of Asthma ... Nitric Oxide #EBM ... #PCC #Asthma #Tezepelumab ... #NEJM
Long-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia #EBM #Peds #Budesonide #BronchopulmonaryDysplasia #BPD #VisualAbstract #NEJM
Bronchopulmonary Dysplasia #EBM ... #Peds #Budesonide ... VisualAbstract #NEJM